JP2001038169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001038169A5 JP2001038169A5 JP1999219790A JP21979099A JP2001038169A5 JP 2001038169 A5 JP2001038169 A5 JP 2001038169A5 JP 1999219790 A JP1999219790 A JP 1999219790A JP 21979099 A JP21979099 A JP 21979099A JP 2001038169 A5 JP2001038169 A5 JP 2001038169A5
- Authority
- JP
- Japan
- Prior art keywords
- inner diameter
- plasma
- membrane
- thickness
- hollow fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 description 29
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 27
- 238000000926 separation method Methods 0.000 description 14
- 239000012510 hollow fiber Substances 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000001112 coagulating effect Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 238000009987 spinning Methods 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- -1 wet heat treatment Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102100027211 Albumin Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11219790A JP2001038169A (ja) | 1999-08-03 | 1999-08-03 | 血漿成分分離膜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11219790A JP2001038169A (ja) | 1999-08-03 | 1999-08-03 | 血漿成分分離膜 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001038169A JP2001038169A (ja) | 2001-02-13 |
| JP2001038169A5 true JP2001038169A5 (enrdf_load_stackoverflow) | 2006-05-11 |
Family
ID=16741073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11219790A Pending JP2001038169A (ja) | 1999-08-03 | 1999-08-03 | 血漿成分分離膜 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001038169A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5580616B2 (ja) * | 2010-02-15 | 2014-08-27 | 東洋紡株式会社 | ポリスルホン系選択透過性中空糸膜束の乾燥方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6391102A (ja) * | 1986-10-03 | 1988-04-21 | Kanegafuchi Chem Ind Co Ltd | 血漿成分分離用膜 |
| JPH01111404A (ja) * | 1987-10-24 | 1989-04-28 | Toyobo Co Ltd | 中空糸型血漿分離膜 |
| JPH0271827A (ja) * | 1988-09-07 | 1990-03-12 | Kuraray Co Ltd | エチレンビニルアルコール系共重合体中空糸膜の製造法 |
| JPH0798061B2 (ja) * | 1989-02-13 | 1995-10-25 | 株式会社クラレ | 血液処理装置 |
| JP2728549B2 (ja) * | 1990-07-04 | 1998-03-18 | 帝人株式会社 | 複合中空糸の製造方法 |
| JPH07148252A (ja) * | 1993-12-01 | 1995-06-13 | Teijin Ltd | 血液浄化用中空糸膜 |
| JPH10108907A (ja) * | 1996-10-08 | 1998-04-28 | Toyobo Co Ltd | 血液浄化膜、その製造方法及び血液浄化用モジュール |
| JP3295321B2 (ja) * | 1996-12-05 | 2002-06-24 | 帝人株式会社 | 選択透過性中空糸膜 |
| JPH10263375A (ja) * | 1997-03-26 | 1998-10-06 | Teijin Ltd | 選択透過性中空糸膜 |
-
1999
- 1999-08-03 JP JP11219790A patent/JP2001038169A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5009824A (en) | Process for preparing an asymmetrical macroporous membrane polymer | |
| CN1240446C (zh) | 血液处理用透析器及其制造方法 | |
| US4874522A (en) | Polysulfone hollow fiber membrane and process for making the same | |
| CN103301759B (zh) | 一种聚砜空心纤维透析膜及其制造方法 | |
| JP2003245526A (ja) | 中空糸膜およびその製造方法、中空糸膜モジュールおよびその製造方法 | |
| JPH10108907A (ja) | 血液浄化膜、その製造方法及び血液浄化用モジュール | |
| AU672856B2 (en) | High flux hollow fiber membrane | |
| JP3714686B2 (ja) | ポリスルホン系中空糸膜及びその製造方法 | |
| JPH06296686A (ja) | 医療用ポリスルホン中空糸膜 | |
| JP2001170172A (ja) | 血液処理用透析器 | |
| JP2001038169A5 (enrdf_load_stackoverflow) | ||
| JPH0245062A (ja) | 血液濃縮器用中空糸膜 | |
| JPH05161836A (ja) | 生体適合性に優れた透過膜 | |
| JPH0194902A (ja) | ポリスルホン中空繊維膜およびその製法 | |
| JP3651121B2 (ja) | 選択透過性分離膜 | |
| JP3995228B2 (ja) | 血液浄化用中空糸膜 | |
| JP3020016B2 (ja) | 中空糸膜 | |
| JP3424807B2 (ja) | 中空糸膜 | |
| JP4003982B2 (ja) | ポリスルホン系選択透過性分離膜 | |
| JP4810720B2 (ja) | 選択除去膜およびそれを用いた血液処理器 | |
| JP2873967B2 (ja) | ポリアクリロニトリル系中空糸膜およびその製造法 | |
| JP2001038154A5 (enrdf_load_stackoverflow) | ||
| JPS6247367A (ja) | 血液濃縮器 | |
| JP4386607B2 (ja) | ポリスルホン系血液浄化膜の製造方法およびポリスルホン系血液浄化膜 | |
| JP4381022B2 (ja) | 中空糸型血液浄化膜 |